Product Information
SYNJARDY 5-1,000 MG TABLET is a brand product labeled by Boehringer Ingelheim Pharmaceuticals Inc., priced at $5.5994 per EA under NDC 00597017518. Its NADAC has been published 542 times since May 18, 2016.
FDA first approved this application on Aug 26, 2015.
Strength
5; 1000 mg/1; mg/1
Manufacturer
Boehringer Ingelheim Pharmaceuticals Inc.NDC
00597017518
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA206111FDA Approved
8/26/2015
On Market Since
8/26/2015
Pharmacological Classes
Price Statistics
The NADAC for SYNJARDY 5-1,000 MG TABLET has been published 542 times since May 18, 2016, and over the history we have for it it has declined 9.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.5994 per EA |
|---|---|
| All-time high | $10.0813 (Nov 12, 2025) |
| All-time low | $5.5959 (Jun 17, 2026) |
| 52-week high | $10.0813 |
| 52-week low | $5.5959 |
| Median price | $8.3726 |
| Average price | $8.2773 |
| Largest weekly change | -44.4% (Jan 7, 2026) |
| Weeks tracked | 542 |
| Tracking since | May 18, 2016 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Boehringer Ingelheim Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
empagliflozin and metformin hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Biguanide class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SYNJARDY 5-1,000 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SYNJARDY 5-1,000 MG TABLET, manufactured by Boehringer Ingelheim Pharmaceuticals Inc., is $5.5994 per EA (NDC 00597017518), effective Sep 30, 2026.
How has the price of SYNJARDY 5-1,000 MG TABLET changed over time?
Over the history we have for it, the NADAC for SYNJARDY 5-1,000 MG TABLET has declined 9.1%. It has been tracked across 542 weekly CMS publications since May 18, 2016.
What are the highest and lowest recorded NADAC prices for SYNJARDY 5-1,000 MG TABLET?
Since May 18, 2016, the NADAC for SYNJARDY 5-1,000 MG TABLET has ranged from a low of $5.5959 (Jun 17, 2026) to a high of $10.0813 (Nov 12, 2025), with a median of $8.3726 per EA.
Are there cheaper alternatives to SYNJARDY 5-1,000 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as SYNJARDY 5-1,000 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures SYNJARDY 5-1,000 MG TABLET?
SYNJARDY 5-1,000 MG TABLET (NDC 00597017518) is labeled by Boehringer Ingelheim Pharmaceuticals Inc., and CMS classifies it as a brand product.